Immune activation and microbial translocation in liver disease progression in HIV/hepatitis co-infected patients: Results from the Icona Foundation study

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Marchetti, Giulia ^a   Cozzi Lepri, Alessandro ^b   Tincati, Camilla ^a   Calcagno, Andrea ^c   Ceccherini Silberstein, Francesca ^d   De Luca, Andrea ^e   Antinori, Andrea ^f   Castagna, Antonella ^g   Puoti, Massimo ^h   Monforte, Antonella D ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF TURIN   (Italy)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

^e UNIVERSITY HOSPITAL OF SIENA   (Italy)

^f NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^g SAN RAFFAELE HOSPITAL   (Italy)

^h OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

Fib 4; HIV hepatitis co infection; Microbial translocation; sCD14

Indexed keywords

BIOLOGICAL MARKER; CD14 ANTIGEN;

ADULT; BLOOD; CD4 LYMPHOCYTE COUNT; COMPLICATION; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROSIS; HEPATITIS A; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; KAPLAN MEIER METHOD; LIVER DISEASE; MALE; MIDDLE AGED; MIXED INFECTION; PATHOPHYSIOLOGY; RISK FACTOR; TREATMENT OUTCOME; VIROLOGY;

ADULT; ANTIGENS, CD14; BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; COINFECTION; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROSIS; HEPATITIS A; HEPATITIS B; HIV INFECTIONS; HUMANS; INFLAMMATION; KAPLAN-MEIER ESTIMATE; LIVER DISEASES; MALE; MIDDLE AGED; RISK FACTORS; TREATMENT OUTCOME;

EID: 84893697505     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-14-79     Document Type: Article

References (19)

1. Paik YH, Schwabe RF, Bataller R, Russo MP, Jobin C, Brenner DA. Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Hepatology 2003, 37(5):1043-1055. PubMed PMID: 12717385. eng, 10.1053/jhep.2003.50182, 12717385.
2. Rubio-Tapia A, Murray JA. The liver in celiac disease. Hepatology 2007, 46(5):1650-1658. PubMed PMID: 17969053. eng, 10.1002/hep.21949, 17969053.
3. Hill GR, Crawford JM, Cooke KR, Brinson YS, Pan L, Ferrara JL. Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines. Blood 1997, 90(8):3204-3213. PubMed PMID: 9376604. eng.
4. Gerbitz A, Schultz M, Wilke A, Linde HJ, Schölmerich J, Andreesen R, et al. Probiotic effects on experimental graft-versus-host disease: let them eat yogurt. Blood 2004, 103(11):4365-4367. PubMed PMID: 14962899. eng, 10.1182/blood-2003-11-3769, 14962899.
5. Sandler NG, Koh C, Roque A, Eccleston JL, Siegel RB, Demino M, et al. Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection. Gastroenterology 2011, 141(4):1220-1230. 30.e1-3. PubMed PMID: 21726511. Pubmed Central PMCID: PMC3186837. eng, 10.1053/j.gastro.2011.06.063, 3186837, 21726511.
6. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006, 12(12):1365-1371. PubMed PMID: 17115046. eng.
7. Marchetti G, Cozzi-Lepri A, Merlini E, Bellistrì GM, Castagna A, Galli M, et al. Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count. AIDS 2011, 25(11):1385-1394. PubMed PMID: 21505312. eng, 10.1097/QAD.0b013e3283471d10, 21505312.
8. Sandler NG, Wand H, Roque A, Law M, Nason MC, Nixon DE, et al. Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis 2011, 203(6):780-790. PubMed PMID: 21252259. Pubmed Central PMCID: PMC3071127. eng, 10.1093/infdis/jiq118, 3071127, 21252259.
9. Balagopal A, Philp FH, Astemborski J, Block TM, Mehta A, Long R, et al. Human immunodeficiency virus-related microbial translocation and progression of hepatitis C. Gastroenterology 2008, 135(1):226-233. PubMed PMID: 18457674. Pubmed Central PMCID: PMC2644903. eng, 10.1053/j.gastro.2008.03.022, 2644903, 18457674.
10. García-Álvarez M, Berenguer J, Guzman-Fulgencio M, Alvarez E, Cosín J, Micheloud D, et al. Bacterial DNA translocation and liver disease severity among HIV-infected patients with chronic hepatitis C. J Acquir Immune Defic Syndr 2012, 61(5):552-556. PubMed PMID: 22932319. eng, 10.1097/QAI.0b013e31826ea109, 22932319.
11. Balagopal A, Gama L, Franco V, Russell JN, Quinn J, Higgins Y, et al. Detection of microbial translocation in HIV and SIV infection using the Limulus amebocyte lysate assay is masked by serum and plasma. PLoS One 2012, 7(8):e41258. PubMed PMID: 22870212. Pubmed Central PMCID: PMC3409852. eng, 10.1371/journal.pone.0041258, 3409852, 22870212.
12. Marchetti G, Nasta P, Bai F, Gatti F, Bellistrì GM, Tincati C, et al. Circulating sCD14 is associated with virological response to pegylated-interferon-alpha/ribavirin treatment in HIV/HCV co-infected patients. PLoS One 2012, 7(2):e32028. PubMed PMID: 22363790. Pubmed Central PMCID: PMC3283684. eng, 10.1371/journal.pone.0032028, 3283684, 22363790.
13. Redd AD, Wendel SK, Grabowski MK, Ocama P, Kiggundu V, Bbosa F, et al. Liver stiffness is associated with monocyte activation in HIV-infected Ugandans without viral hepatitis. AIDS Res Hum Retroviruses 2013, 29(7):1026-1030. PubMed PMID: 23548102. Pubmed Central PMCID: PMC3685686. eng, 10.1089/aid.2013.0004, 23548102.
14. Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006, 43(6):1317-1325. PubMed PMID: 16729309. eng, 10.1002/hep.21178, 16729309.
15. Vallet-Pichard A, Mallet V, Nalpas B, Verkarre V, Nalpas A, Dhalluin-Venier V, et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatology 2007, 46(1):32-36. PubMed PMID: 17567829. eng, 10.1002/hep.21669, 17567829.
16. Fernández-Real JM, López-Bermejo A, Broch M, Vendrell J, Richart C, Ricart W. Circulating soluble CD14 monocyte receptor is associated with increased alanine aminotransferase. Clin Chem 2004, 50(8):1456-1458. PubMed PMID: 15277359. eng, 10.1373/clinchem.2003.030015, 15277359.
17. Wurfel MM, Hailman E, Wright SD. Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein. J Exp Med 1995, 181(5):1743-1754. PubMed PMID: 7536794. Pubmed Central PMCID: PMC2191991. eng, 10.1084/jem.181.5.1743, 2191991, 7536794.
18. Kitchens RL, Thompson PA, Viriyakosol S, O'Keefe GE, Munford RS. Plasma CD14 decreases monocyte responses to LPS by transferring cell-bound LPS to plasma lipoproteins. J Clin Invest 2001, 108(3):485-493. PubMed PMID: 11489942. Pubmed Central PMCID: PMC209364. eng, 10.1172/JCI200113139, 209364, 11489942.
19. Seki E, De Minicis S, Osterreicher CH, Kluwe J, Osawa Y, Brenner DA, et al. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med 2007, 13(11):1324-1332. PubMed PMID: 17952090. eng, 10.1038/nm1663, 17952090.